Yorktown Management & Research Company’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-8,200
| Closed | -$411K | – | 256 |
|
|
2021
Q3 | $411K | Hold |
8,200
| – | – | 0.31% | 137 |
|
|
2021
Q2 | $517K | Buy |
8,200
+3,800
| +86% | +$240K | 0.41% | 83 |
|
|
2021
Q1 | $409K | Hold |
4,400
| – | – | 0.34% | 101 |
|
|
2020
Q4 | $394K | Hold |
4,400
| – | – | 0.35% | 136 |
|
|
2020
Q3 | $455K | Hold |
4,400
| – | – | 0.43% | 66 |
|
|
2020
Q2 | $348K | Hold |
4,400
| – | – | 0.31% | 104 |
|
|
2020
Q1 | $255K | Hold |
4,400
| – | – | 0.26% | 155 |
|
|
2019
Q4 | $237K | Hold |
4,400
| – | – | 0.13% | 243 |
|
|
2019
Q3 | $230K | Hold |
4,400
| – | – | 0.12% | 255 |
|
|
2019
Q2 | $213K | Hold |
4,400
| – | – | 0.08% | 273 |
|
|
2019
Q1 | $222K | Hold |
4,400
| – | – | 0.07% | 291 |
|
|
2018
Q4 | $261K | Sell |
4,400
-1,600
| -27% | -$94.9K | 0.09% | 264 |
|
|
2018
Q3 | $395K | Hold |
6,000
| – | – | 0.12% | 186 |
|
|
2018
Q2 | $303K | Sell |
6,000
-2,600
| -30% | -$131K | 0.09% | 264 |
|
|
2018
Q1 | $453K | Hold |
8,600
| – | – | 0.13% | 149 |
|
|
2017
Q4 | $400K | Hold |
8,600
| – | – | 0.12% | 169 |
|
|
2017
Q3 | $348K | Hold |
8,600
| – | – | 0.09% | 167 |
|
|
2017
Q2 | $292K | Hold |
8,600
| – | – | 0.09% | 162 |
|
|
2017
Q1 | $250K | Hold |
8,600
| – | – | 0.07% | 259 |
|
|
2016
Q4 | $282K | Buy |
+8,600
| New | +$282K | 0.07% | 168 |
|